Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the ...

In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

This can be difficult in a household with cats that like to graze throughout the day. If this problem sounds familiar, you ...

Emerging research has linked COVID-19 to joint pain and osteoarthritis, but the precise mechanisms behind this connection and ...

The company had focused its resources on Filspari’s launch in IgAN after the US FDA snubbed the therapy in another rare ...

Investigators say more research is warranted to optimize management of patients with pulmonary arterial hypertension (PAH) ...

The Food and Drug Administration (FDA) has granted full approval to Filspari ® (sparsentan) to slow kidney function decline in adults with primary immunoglobulin A (IgA) nephropathy who are at risk ...

The US Food and Drug Administration has granted full approval to sparsentan (Filspari) for reduction of proteinuria in adults ...

Two abstracts win the prestigious AHA 2024 Paul Dudley White International Scholar Award Allschwil, Switzerland – September 5 ...

The European approval comes months after the FDA’s approval of the first-of-its-kind treatment for pulmonary arterial ...